188 related articles for article (PubMed ID: 8509359)
1. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.
Screaton GR; Bell MV; Bell JI; Jackson DG
J Biol Chem; 1993 Jun; 268(17):12235-8. PubMed ID: 8509359
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 variant transcripts in dog lymphatic tissue.
Milde KF; Alejandro R; Pastori RL
Immunogenetics; 1994; 40(6):437-44. PubMed ID: 7525471
[TBL] [Abstract][Full Text] [Related]
3. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
[TBL] [Abstract][Full Text] [Related]
4. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
Screaton GR; Bell MV; Jackson DG; Cornelis FB; Gerth U; Bell JI
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12160-4. PubMed ID: 1465456
[TBL] [Abstract][Full Text] [Related]
5. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain.
Jackson DG; Buckley J; Bell JI
J Biol Chem; 1992 Mar; 267(7):4732-9. PubMed ID: 1537855
[TBL] [Abstract][Full Text] [Related]
6. The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44.
Cooper DL; Dougherty G; Harn HJ; Jackson S; Baptist EW; Byers J; Datta A; Phillips G; Isola NR
Biochem Biophys Res Commun; 1992 Jan; 182(2):569-78. PubMed ID: 1734871
[TBL] [Abstract][Full Text] [Related]
7. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
Yu Q; Toole BP
J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
[TBL] [Abstract][Full Text] [Related]
8. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
9. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA
Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117
[TBL] [Abstract][Full Text] [Related]
10. Splicing choice from ten variant exons establishes CD44 variability.
Tölg C; Hofmann M; Herrlich P; Ponta H
Nucleic Acids Res; 1993 Mar; 21(5):1225-9. PubMed ID: 8464707
[TBL] [Abstract][Full Text] [Related]
11. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
Hirano H; Screaton GR; Bell MV; Jackson DG; Bell JI; Hodes RJ
Int Immunol; 1994 Jan; 6(1):49-59. PubMed ID: 7511928
[TBL] [Abstract][Full Text] [Related]
12. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
[TBL] [Abstract][Full Text] [Related]
13. Structure and expression of the mouse growth hormone receptor/growth hormone binding protein gene.
Moffat JG; Edens A; Talamantes F
J Mol Endocrinol; 1999 Aug; 23(1):33-44. PubMed ID: 10425445
[TBL] [Abstract][Full Text] [Related]
14. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
15. Genomic structure of the locus encoding protein 4.1. Structural basis for complex combinational patterns of tissue-specific alternative RNA splicing.
Huang JP; Tang CJ; Kou GH; Marchesi VT; Benz EJ; Tang TK
J Biol Chem; 1993 Feb; 268(5):3758-66. PubMed ID: 8429050
[TBL] [Abstract][Full Text] [Related]
16. Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.
Tanabe KK; Nishi T; Saya H
Mol Carcinog; 1993; 7(4):212-20. PubMed ID: 8352881
[TBL] [Abstract][Full Text] [Related]
17. A PCR-based method for the analysis of human CD44 splice products.
van Weering DH; Baas PD; Bos JL
PCR Methods Appl; 1993 Oct; 3(2):100-6. PubMed ID: 7505677
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CD44 alternative splicing variants in lung cancer].
Ohgami A; Sugio K; Mitsudomi T; Tsuda T; Yasumoto K
Nihon Rinsho; 1995 Jul; 53(7):1704-9. PubMed ID: 7630011
[TBL] [Abstract][Full Text] [Related]
19. Cloning and functional expression of the luteinizing hormone receptor complementary deoxyribonucleic acid from the marmoset monkey testis: absence of sequences encoding exon 10 in other species.
Zhang FP; Rannikko AS; Manna PR; Fraser HM; Huhtaniemi IT
Endocrinology; 1997 Jun; 138(6):2481-90. PubMed ID: 9165039
[TBL] [Abstract][Full Text] [Related]
20. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
